Pentaethylene Glycol

Pentaethylene Glycol

SCHEMBL672104

C=C(C)C(=O)O.C=C(C)C(=O)O.OCCOCCOCCOCCOCCO

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
TSHR P16473 9/20 0.48
MAPK1 P28482 1/20 0.48
THRB P10828 2/20 0.42
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.41
ALDH1A1 P00352 5/20 0.40
TP53 P04637 2/20 0.33
HIF1A Q16665 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TGFBR1 P36897 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL8604056 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Triethylene Glycol SCHEMBL976431 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Methacrylic Acid SCHEMBL9485971 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Hexaethylene Glycol SCHEMBL2347830 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Triethylene Glycol SCHEMBL8661497 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Methacrylic Acid SCHEMBL10529387 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Methacrylic Acid SCHEMBL478108 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Tetraethylene Glycol SCHEMBL9314003 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Tetraethylene Glycol SCHEMBL33688 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
Methacrylic Acid SCHEMBL478199 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119920967-A Liquid crystal-based polymer solid electrolyte composition, liquid crystal-based polymer solid electrolyte, preparation method of liquid crystal-based polymer solid electrolyte and lithium metal battery 中国石油化工股份有限公司 2025-05-02 CN claimed
CN-119501060-A Composition for preparing porous metal structure and three-dimensional phase-change heat dissipation porous structure 苏州铜宝锐新材料有限公司 2025-02-25 CN claimed
CN-119425609-A Iron ion silicon-based adsorption material and preparation method and application thereof 中国科学院赣江创新研究院 2025-02-14 CN claimed
CN-112912971-B conductive paste 藤仓化成株式会社 2023-09-26 CN claimed
US-20230109529-A1 POLYMERIZABLE COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2023-04-06 US claimed
EP-4155783-A1 POLYMERIZABLE COMPOSITION Daikin Industries, Ltd. (JP) 2023-03-29 EP claimed
CN-115668004-A Polymerizable composition 大金工业株式会社 2023-01-31 CN claimed
CN-107664919-B Method for producing patterned cured product and patterned cured product obtained thereby 三星显示有限公司 2022-10-14 CN claimed
US-10744684-B2 Method of preparing patterned cured product and patterned cured product obtained using the method SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-18 US claimed
US-20180029255-A1 METHOD OF PREPARING PATTERNED CURED PRODUCT AND PATTERNED CURED PRODUCT OBTAINED USING THE METHOD SAMSUNG DISPLAY CO., LTD. (KR) 2018-02-01 US claimed
US-7078157-B2 Photosensitive composition and use thereof AZ ELECTRONIC MATERIALS USA CORP. (US) 2006-07-18 US claimed
EP-1602010-A2 PHOTOSENSITIVE COMPOSITION AND USE THEREOF AZ Electronic Materials USA Corp. (US) 2005-12-07 EP claimed
WO-2004077153-A2 PHOTOSENSITIVE COMPOSITION AND USE THEREOF AZ ELECTRONIC MATERIALS USA CORP. (US) 2004-09-10 WO claimed
US-20040175653-A1 Photosensitive composition and use thereof AZ ELECTRONIC MATERIALS USA CORP. 2004-09-09 US claimed
US-4380432-A METHACRYLATE, CONJUGATED DIENE ELASTOMER SCIENTIFIC PHARMACEUTICALS (US) 1983-04-19 US claimed
US-20260140398-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2026-05-21 US disclosed
US-12609210-B2 Curable composition and cured body of same TOKUYAMA CORPORATION (JP) 2026-04-21 US disclosed
US-4058491-A Cationic hydrogels based on heterocyclic N-vinyl monomers PLASTOMEDICAL SCIENCES, INC. (US) 1977-11-15 US disclosed
US-4039705-A SHEETS AND TAPES, TWO DIFFERENTIAL RELEASE SURFACES AVERY INTERNATIONAL CORPORATION (US) 1977-08-02 US disclosed
US-4036788-A Anionic hydrogels based on heterocyclic N-vinyl monomers PLASTOMEDICAL SCIENCES, INC. (US) 1977-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12609210-B2 Curable composition and cured body of same UACA, MMAB, SMCHD1 MEN1 37/4885KMT2A 2580/4885TSHR 960/4885
US-20260140398-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES CRYAA, FEM1B, MAPRE1 MEN1 38/4885KMT2A 1581/4885TSHR 4218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.